Overview of the microarray market
Extensive research carried out by the analysts at Technavio has shown that the global microarray market is expected to witness tremendous growth and will post a staggering CAGR of more than 14% during the forecast period. One of the primary factors driving this market’s growth is the emergence of microarrays in genomics and proteomics. These technologies are used for genotyping, mutation screening, protein interaction studies, and gene expression analysis. For instance, DNA microarray technology is used to develop new gene expression patterns across gene families, expand gene family size, and discover new categories of genes. Moreover, microarray technology can also be used to disease diagnosis, which will eventually aid in determining better treatment strategies. Although microarray is an expensive technology, its extensive applications in the healthcare sector due to its portability, rapid assay times, and fewer sample requirements will lead to its augmented adoption in the future.
In terms of geographical regions, the Americas was the highest revenue-contributing region in the global microarray market during 2015. The market will continue to be led by the Americas over the next four years due to an increase in research investments made by several biotechnology and pharmaceutical companies to develop targeted therapeutics using microarray technologies, such as tissue, DNA, and protein microarray solutions. Also, the region is home to several big pharmaceutical companies which conduct gene testing using various microarray technologies, including DNA microarray, LOC, protein microarray, and tissue microarray. North America will be the key revenue contributor in the region owing to a
Overview of the global chromatography market
According to the market research analysts at Technavio, the global chromatography market is anticipated to witness steady growth and will post a moderate CAGR of more than 5% during the forecast period. The rapid automation of sample handling processes in the laboratories and research facilities is one of the primary factors driving this market’s growth. Sample handling equipment replace the need for manual manipulation and helps streamline experiments. Laboratory automation is widely adopted in the fields of biology and chemistry, particularly in applications such as high-throughput screening, automated clinical and analytical testing, diagnostics, combinatorial chemistry, and large-scale biorepositories. Automation of sampling handling processes not only reduces the chances of error but also allows greater control and precision of the quantity of the sample or solution to be used. Moreover, the integration of automated systems in the sample handling, separation, and purification processes in chromatography has led to the introduction of several new instruments and accessories that can work in tandem with chromatography instruments.
In terms of geography, the Americas led the market and will continue to dominate the market during the forecast period. The chromatography market in the Americas is led by the US and Canada. The growth of this market in the region is attributed to the increasing adoption of highly advanced chromatic techniques by the pharmaceutical and
Overview of the breath analyzers market
Extensive research carried out by the analysts at Technavio has shown that the global breath analyzers market will witness exponential growth and post a tremendous CAGR of more than 25% over the forecast period. The increasing demand for breath analyzers has led to the manufacturers introducing several innovations in the product, which is expected to have a positive impact on this market’s growth in the coming years. The technology used in breath analyzers has been around for decades, whether it is infrared, semiconductor, or fuel cell sensors. The challenge to reduce the size and processing time of these devices to a minimum, without compromising on the accuracy of the sensor, was met by the evolution of integrated circuits and the miniaturization of electronics. Moreover, some of these breath analyzers can also be connected to a smartphone via microUSB or Bluetooth, allowing the users to track BAC and health conditions using an application on their smartphones. The reduction in size and introduction of nifty features in breath analyzers will lead to their augmented adoption over the next four years.
In terms of geography, the Americas led the market and is likely to account for over 47% of the revenue market shares by 2020. Factors such as stringent road safety regulations relatively stronger infrastructure of law enforcement agencies will drive the market in this region. The US was the highest revenue contributor in the region as it is home to some of the biggest companies in this market such as Lifeloc Technologies, BACtrack, Quest Products, Intoximeter, and Akers Biosciences, thereby giving consumers access to a wider range of products.
Competitive landscape and key vendors
Global market overview for DNA microarrays
According to the analysts at Technavio, the global market for DNA microarrays will experience promising growth during the estimated period and will be affected by factors like the rising popularity of personalized medicines. During the forecast period, it is estimated that the popularity of DNA microarray technology will increase significantly as it helps in the early detection of diseases and selection of accurate treatment methods, which reduces mortality rates. This technology also enables researchers to analyze critical biological complications such as genomic variations and the nature of inherited syndromes that cause cardiovascular diseases and cancers. The ability of this technology to perform gene profiling of patients, understand the risk of clinical outcomes, and study an individual's response to specific drugs, will result in this market’s impressive CAGR of over 15% by 2020.
In terms of geography, the Americas will be the largest market for DNA microarrays and will continue its market dominance until the end of 2020. Much of this market’s growth in the Americas can be attributed to the recent increase in the number of age-related chronic diseases, which will, in turn, necessitate the utilization of technologies such as DNA microarrays for testing and development of new drugs. Additionally, the recent increase in investments by biotechnology and pharmaceutical companies to develop targeted therapeutics using DNA microarray solutions will result in this region’s market dominance during the estimated period.
Competitive landscape and key vendors
The global DNA microarray market is extremely
Overview of the RFID blood refrigerator and freezer market
RFID blood refrigerators and freezers are storage equipment that is used to store, track, monitor, and control blood and blood products inventory for better operational efficiency. A surge in the number of diagnostic centers is one of the most important factors driving this market’s growth. In the recent years, diagnostic testing has gradually shifted from hospitals and diagnostic centers to the patient’s home, which increases convenience and is cost-effective. Moreover, given the percentage of total rural area population in major countries, many RFID blood storage solution providers are looking to venture into these countries to capitalize on the untapped storage solutions market. The majority of patients in the rural areas postpone diagnosis and treatment of chronic diseases due to difficulty in availing transport, lack of accessible healthcare facilities, and marginally low-income levels. The increasing number of diagnostic centers to meet the growing patient population globally has driven the need to store blood and blood products used for treating diseases and performing surgeries. RFID blood refrigerators and freezers have helped diagnostic centers in reducing physical inventory counting by tracking it automatically at the point of use, thereby decreasing the overall operational cost and increasing the profitability of diagnostic centers. According to the market research analysts at Technavio, the RFID blood refrigerators and freezer market will grow exponentially and will post a staggering CAGR of close to 22% over the estimated period.
In terms of geography, the Americas was the largest revenue contributing region in the market in 2015 and is expected to account for close to 53% of the total market shares by 2020. The
Global outlook of the biopsy devices market
Technavio’s market research analysts have predicted that the global biopsy devices market will grow steadily at a CAGR of more than 6% by 2020. The recent years have seen a worldwide increase in the prevalence of liver diseases, which is mainly due to reasons like alcohol consumption, obesity, and viral hepatitis. Imaging tests such as X-rays and CT scans are efficient in identifying areas of concern but cannot distinguish between cancerous and non-cancerous cells. Liver biopsy provides an accurate way of detecting the disease and disorder present in the liver, where a needle is inserted into the organ to remove a small piece of tissue that can be later examined under a microscope for signs of disease or damage. An increase in the number of liver diseases has led to the rise in awareness for regular diagnosis of the liver condition, which in turn, will lead to the growth in the number of liver biopsy tests.
In terms of geography, the Americas will account for more than 51% of the total share of the market and will dominate the industry throughout the forecast period. This attributes to the availability of highly developed healthcare infrastructure that provides people with easy access to advanced diagnostic tests. The US and Canada are the major contributors to the market. The awareness among people about the importance of the early diagnosis of cancer will drive the demand for biopsy instruments.
Competitive landscape and key vendors
The market is largely diversified due to the presence of several international and regional players. Leading vendors such as BD, COOK Medical, C.R. Bard, and Devicor Medical